Literature DB >> 8880572

Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.

M Decruyenaere1, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe.   

Abstract

For people at risk for Huntington's disease, the anxiety and uncertainty about the future may be very burdensome and may be an obstacle to personal decision making about important life issues, for example, procreation. For some at risk persons, this situation is the reason for requesting predictive DNA testing. The aim of this paper is two-fold. First, we want to evaluate whether knowing one's carrier status reduces anxiety and uncertainty and whether it facilitates decision making about procreation. Second, we endeavour to identify pretest predictors of psychological adaptation one year after the predictive test (psychometric evaluation of general anxiety, depression level, and ego strength). The impact of the predictive test result was assessed in 53 subjects tested, using pre- and post-test psychometric measurement and self-report data of follow up interviews. Mean anxiety and depression levels were significantly decreased one year after a good test result; there was no significant change in the case of a bad test result. The mean personality profile, including ego strength, remained unchanged one year after the test. The study further shows that the test result had a definite impact on reproductive decision making. Stepwise multiple regression analyses were used to select the best predictors of the subject's post-test reactions. The results indicate that a careful evaluation of pretest ego strength, depression level, and coping strategies may be helpful in predicting post-test reactions, independently of the carrier status. Test result (carrier/ non-carrier), gender, and age did not significantly contribute to the prediction. About one third of the variance of post-test anxiety and depression level and more than half of the variance of ego strength was explained, implying that other psychological or social aspects should also be taken into account when predicting individual post-test reactions.

Entities:  

Keywords:  Belgium; Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1996        PMID: 8880572      PMCID: PMC1050726          DOI: 10.1136/jmg.33.9.737

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  20 in total

1.  The Tiresias complex: Huntington's disease as a paradigm of testing for late-onset disorders.

Authors:  N S Wexler
Journal:  FASEB J       Date:  1992-07       Impact factor: 5.191

2.  An ego-strength scale which predicts response to psychotherapy.

Authors:  F BARRON
Journal:  J Consult Psychol       Date:  1953-10

3.  Exploration of the effects of predictive testing for Huntington disease on intimate relationships.

Authors:  K A Quaid; M K Wesson
Journal:  Am J Med Genet       Date:  1995-05-22

4.  Uptake of presymptomatic predictive testing for Huntington's disease.

Authors:  D Craufurd; A Dodge; L Kerzin-Storrar; R Harris
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

5.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

6.  Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

Authors:  A Tyler; D Ball; D Craufurd
Journal:  BMJ       Date:  1992-06-20

7.  Factors influencing the reproductive decision after genetic counseling.

Authors:  P G Frets; H J Duivenvoorden; F Verhage; M F Niermeijer; S M van de Berge; H Galjaard
Journal:  Am J Med Genet       Date:  1990-04

8.  Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

Authors:  M Huggins; M Bloch; S Wiggins; S Adam; O Suchowersky; M Trew; M Klimek; C R Greenberg; M Eleff; L P Thompson
Journal:  Am J Med Genet       Date:  1992-02-15

9.  Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.

Authors:  M Bloch; S Adam; S Wiggins; M Huggins; M R Hayden
Journal:  Am J Med Genet       Date:  1992-02-15

10.  Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.

Authors:  M Bloch; M Fahy; S Fox; M R Hayden
Journal:  Am J Med Genet       Date:  1989-02
View more
  36 in total

1.  Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.

Authors:  L N Lodder; P G Frets; R W Trijsburg; E J Meijers-Heijboer; J G Klijn; H J Duivenvoorden; A Tibben; A Wagner; C A van der Meer; P Devilee; C J Cornelisse; M F Niermeijer
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

Review 2.  Psychological impact of genetic testing for Huntington's disease: an update of the literature.

Authors:  B Meiser; S Dunn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 3.  Psychological effect of genetic testing for Huntington's disease: an update of the literature.

Authors:  B Meiser; S Dunn
Journal:  West J Med       Date:  2001-05

4.  Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal, and ethical viewpoints.

Authors:  Ros Tassicker; Julian Savulescu; Loane Skene; Pam Marshall; Lara Fitzgerald; Martin B Delatycki
Journal:  BMJ       Date:  2003-02-08

Review 5.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

6.  What were you thinking?: individuals at risk for Huntington Disease talk about having children.

Authors:  Kimberly A Quaid; Melinda M Swenson; Sharon L Sims; Joan M Harrison; Carol Moskowitz; Nonna Stepanov; Gregory W Suter; Beryl J Westphal
Journal:  J Genet Couns       Date:  2010-08-24       Impact factor: 2.537

7.  Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.

Authors:  M Decruyenaere; G Evers-Kiebooms; A Boogaerts; J J Cassiman; T Cloostermans; K Demyttenaere; R Dom; J P Fryns
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

Review 8.  Why tell asymptomatic children of the risk of an adult-onset disease in the family but not test them for it?

Authors:  P J Malpas
Journal:  J Med Ethics       Date:  2006-11       Impact factor: 2.903

9.  Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.

Authors:  Lisa M Pastore; Logan B Karns; Karen Ventura; Myra L Clark; Richard H Steeves; Nancy Callanan
Journal:  J Genet Couns       Date:  2013-06-14       Impact factor: 2.537

10.  Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.